Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Almirall ( (ES:ALM) ) has shared an announcement.
Almirall will present and discuss its 2025 financial results in a webcast with analysts and institutional investors on 23 February 2026 at 10:00 a.m. CET. The event, which can be followed live and later via full recording on the company’s website, underlines Almirall’s ongoing commitment to financial transparency and engagement with the capital markets.
The webcast is positioned as a key touchpoint for investors to assess the company’s recent performance and outlook based on the disclosed figures. By facilitating direct access to management’s commentary for both live and replay audiences, Almirall supports informed decision-making for shareholders and market participants.
The most recent analyst rating on (ES:ALM) stock is a Hold with a EUR14.00 price target. To see the full list of analyst forecasts on Almirall stock, see the ES:ALM Stock Forecast page.
More about Almirall
Almirall, S.A. is a Barcelona-based pharmaceutical company operating in the healthcare industry. It focuses on developing and marketing medicines and treatments, targeting patients, healthcare professionals and institutional stakeholders in its core therapeutic areas.
Average Trading Volume: 200,021
Technical Sentiment Signal: Buy
Current Market Cap: €2.97B
See more insights into ALM stock on TipRanks’ Stock Analysis page.